A study published in The Lancet claimed that chloroquine and hydroxychloroquine increases the risk of death in COVID-19 patients.

But the data used in this study appear to have been “completely fabricated”, “in what is possibly a criminal conspiracy” according to Peter Ellis, a professional statistician and data scientist.

The Lancet paper was retracted on June 5, 2020, and the world Health Organization resumed trials of hydroxychloroquine for treating Covid-19, which had been stopped due to this “study”.

Twenty percent (20%) of people given the high dose Covid-19 vaccine, being developed by Moderna, and being championed by Anthony Fauci, had a “serious adverse event” within 43 days as noted in an Instagram Post on May 19,2020 by Senator Robert F. Kennedy, Jr.

“Arguably, the Covid crisis is being presented in such a one-sided, misleading and alarmist manner that the public is effectively being lied to,” writes Sherelle Jacobs in an article published in The Telegraph on May 14, 2020.

William O’Neill, MD, a cardiologist and a medical director at Henry Ford Health System in Detroit, Michigan, has given hydroxychloroquine to help numerous COVID-19 patient and saw improvement in all of them as noted in an interview by Sharyl Attkisson on the TV show Full Measure which aired on May 17, 2020.

William O’Neill, MD, a cardiologist and a medical director at Henry Ford Health System in Detroit, Michigan, says that he as well as his colleagues at the University of Washington—I am going to guess that he meant to say Washington University, which is in St. Louis, Missouri—and the University of Minnesota have given hydroxychloroquine to help 400 COVID-19 patients, and they have not seen any adverse effects as noted in an interview by Sharyl Attkisson on the TV show Full Measure which aired on May 17, 2020.

Here is a one-minute video clip of Ivette Lozano, MD from Dallas, Texas talking about her experience with giving hydroxychloroquine to Covid-19 patients.

She talks about how pharmacists are giving her a hard time about prescriptions for hydroxychloroquine, and even refusing to fill the prescriptions, and that people are coming from all over Texas because their doctors are afraid to prescribe hydroxychloroquine for fear of getting in trouble with the licensing board.

“[Dr. Deborah] Birx and others were frustrated with the CDC’s antiquated system for tracking virus data, which they worried was inflating some statistics — such as mortality rate and case count — by as much as 25 percent, according to four people present for the discussion or later briefed on it” according to an article from The Washington Post posted on May 9, 2020.

“There is nothing from the CDC that I can trust,” Birx said, according to two of the people.

Dr. Deborah Birx is the physician who oversees the administration’s coronavirus response for Covid-19.

On April 29, 2020 Dr. Anthony Fauci, one of the leads on the coronavirus Task Force for the White House on Covid-19, said that there is “clearcut evidence” that Remdesivir works for Covid-19, and that it is now the new “standard of care.”

Here are the results of another study that questions whether this is true or not.

A randomized, placebo-controlled Chinese trial found that 15% of those with Covid-19 given remdesivir died versus 13% of those given a placebo.

In other words, people given remdesivir were more likely to die than those given a placebo.

Among 568 critically-ill patients treated in a similar manner, 45.8% of those not given hydroxychloroquine died (238/520) versus 18.8% of those given hydroxychloroquine (9/48) — 200 mg twice a day for 7-10 days — according to a retrospective study from China.

I do not believe the Veterans Administration (VA) hydroxychloroquine study which seems to suggest that they drug increases the risk of death in Covid-19 patients.

They only reported on 70 deaths through April 11, 2020, but a graph on Stars & Stripes website shows that there were roughly 210 people who had died of this date.

It appears that the VA study left out two-thirds of the data.

States that have stay-at-home lockdown orders do not have fewer cases of Covid-19 per million people and do not have fewer deaths from Covid-19 per million people than states that used only social distancing according to political scientist Wilfred Reilly.

“the social-distancing states… [plus South Carolina] experienced 663 fewer cases per million and 42 fewer deaths per million on average than the lockdown states [minus New York],” notes Reilly.

Senator Dr. Scott Jensen said that he received a document from the Minnesota Deptartment of Health coaching him on how to fill out death certificates, listing Covid-19 as the cause of death if there was any suspicion that it might be involved.

Covid-19 is 50-85 times less fatal than previously thought based on a study done by Dr. John Ioannidis from Stanford University which tested people in Santa Clara county, California for antibodies to the virus, showing that they had already been infected.

Here are video highlights from an interview that Del Bigtree of The Highwire did with biostatistician and epidemiologist Knut Wittkowski, PhD, DSc, who was Head of Rockefeller University’s Department of Biostatistics, Epidemiology, and Research Design, about whether social distancing will reduce the number of deaths from coronavirus, Covid-19.

Knut Wittkowski says, no, social distancing will not reduce the number of deaths from Covid-19, and will probably increase the number of people who will die from the virus.

He says there is no evidence anywhere in the world that this is true because the number of deaths had already peaked before social distancing was instituted.

Data suggesting that hydroxychloroquine may be effective for preventing Covid-19 comes from the low number of cases in Africa where they use these drugs to prevent malaria according to some health officials.

Here are highlights from an article in the Wall Street Journal written by two doctors for using hydroxychloroquine plus azithromycin for treating people with Covid-19.

They say:

“Use this treatment cocktail early, and don’t wait until a patient is on a ventilator in the intensive-care unit.”

UK epidemiologist Neil Ferguson who predicted that 500,000 people in the UK would die from COVID-19, drastically reduced his estimate to 20,000 or less — a 25-fold reduction or more—according to an article on the DailyWire.com.

He also predicted that 2.2 million people in the US would die from COVID-19, which also would be a dramatical overestimate.

Hydroxychloroquine (200 mg three times a day) eliminated the coronavirus COVID-19 in 75% of patients after 6 days, while hydroxychloroquine plus the antibiotic azithromycin (500 mg on day 1 followed by 250 mg per day for the next four days) eliminated the virus in 95% of patients after 6 days according to a study done by French biologist and Infectious Disease Specialist, Prof. Didier Raoult, MD, PhD as noted in an article on Medscape.

“It would be a medical mistake not to give chloroquine [or hydroxychloroquine] against the Chinese virus [coronavirus COVID-19],” notes French Biologist and Infectious Disease Specialist Prof. Didier Raoult, MD, PhD in an interview posted on Archyde.com.

Niacin lowers the risk of a major coronary event (heart attack, death from heart attack or coronary bypass surgery) by an average of 25% according to a meta-analysis of eleven (11) studies which involved a total of 6545 people.

Niacin lowers the risk of a stroke by an average of 26% according to a meta-analysis of eleven (11) studies which involved a total of 6545 people.

Niacin raises HDL cholesterol levels by an average of 20% notes a paper on niacin.

Niacin lowers LDL cholesterol levels by an average of 16% notes a paper on niacin.

Niacin lowers triglyceride levels by an average of 20% notes a paper on niacin.

Extended-release niacin (1500 to 2000 mg per day) lowers levels of C-reactive protein (CRP) by an average of 24% in people starting with higher levels of Lp(a)—starting levels of 92 mg/dL versus 54 mg/dL—according to a study from Russia.

Elevated levels of C-reative protein—above 2 mg/dL—are associated with an increased risk of heart and stroke as noted by the Mayo Clinic.

Note: I prefer immediate-release niacin to extended-release niacin. In the 1980’s there were reports of some liver problems with extended-release niacin, and earlier studies showing benefits of niacin used immediate-release niacin, not extended-release.

It turns out that placebos used in some (most?) drug trials are not inert substances.

Instead they contain active ingredients which cause similar adverse events in the placebo group as the drug group.

Men with the highest one-third hair mercury content—2 mcg of mercury per gram of hair or higher—were 38% more likely to die during an average follow-up of 13.9 years compared with men in the lower two-thirds according to a study from Finland which followed 1871 Finnish men aged 42 to 60 years free of previous coronary heart disease or stroke at baseline.

Men with the highest one-third hair mercury content—2 mcg of mercury per gram of hair or higher—were 56% more likely to develop coronary heart disease, 68% more likely to develop cardiovascular disease (heart attack or stroke), and 60% more likely to have an acute coronary event during an average follow-up of 13.9 years compared with men in the lower two-thirds according to a study from Finland which followed 1871 Finnish men aged 42 to 60 years free of previous coronary heart disease or stroke at baseline.

The one-fifth of men with the highest toenail mercury levels were 2.2 times more likely to have a heart attack compared to the one-fifth of men with the lowest levels according to a study which looked at 684 men from eight (8) European countries and Israel who had a heart attack and compared them to 724 men selected to be representative of the same populations.

“There is so much evidence to show that it is not cholesterol [that increases heart attack risk],” notes Prof. Timothy Noakes, MD, DSc, PhD in an interview that he did on a Fat & Furious podcast.

“Cholesterol is a terribly poor predictor of heart attack risk.”

“It is so pathetic…”

Tart cherry juice shortened the amount of time to fall asleep from 31 minutes to 21 minutes, and increases sleep time by 39 minutes according to a study of 10 men and 10 women.

Acetaminophen (Tylenol) use during pregnancy increases the risk of autism 2.1-fold to 3.6-fold and increases the risk of ADHD 2.3-fold to 2.9-fold.

They compared the bottom one-third to the middle one-third to the top one-third for acetaminophen exposure.

Autism and ADHD are caused by different levels of mercury toxicity according to Boyd Haley, PhD, the leading expert on mercury toxicity.

The first cases of autism were identified in 1943 by Leo Kanner.

They started putting mercury in vaccines and on seed corn in the early-1930’s.

“Unless LDL levels are… 300 mg/dL or higher, they have no value, in isolation, in predicting those individuals at risk of [coronary heart disease].”
— William Castelli, 1996; as noted in this 35-second video clip of cardiologist Dr. Aseem Malhotra.

Low serum magnesium levels were associated with an 11% greater risk of coronary disease in men and a 52% greater risk in women during a 27-year followup according to a study of 14,446 people.

The study compared the top one-fifth to the bottom one-fifth.

Higher water intake (more than 1.7 liters) was associated with a 12% lower risk of dying from cardiovascular disease in men, and a 21% lower risk of dying from cardiovascular disease in women compared to those consuming less than 1 liter of water per day according to a study from Japan.

General health checks do not reduce the risk of dying from heart attack, stroke, cancer or dying overall over some number of years according to an updated review by Prof. Peter Gøtzsche, MD and two other authors from the Nordic Cochrane Centre.

“Our data support a protective role for [higher LDL levels] against all-cause mortality following incident [heart attack] and [heart failure],” concludes a new study from researchers at the Mayo Clinic.

LDL levels above 130 mg/dL were most protective.

“Preclinical studies consistently show the robust disease-modifying efficacy of intermittent fasting in animal models on a wide range of chronic disorders, including obesity, diabetes, cardiovascular disease, cancers, and neurodegenerative brain diseases,” notes a review paper on Intermittent fasting published in the New England Journal of Medicine.